CapIQ

Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-08-03.

CapIQ

Copart's forward tape was cut hard through the winter — FY2027 revenue and normalized EPS both fell 5% to 7% over six months — but has been flat for the past three, so consensus looks to have found a floor. The company keeps beating on EPS even as revenue runs light of forecasts. The street models a broadly flat FY2026, then high-single-digit growth, though coverage past FY2027 thins to a handful of analysts. Ratings split evenly, five buys against five holds.

Source: derived from vendor data.

The tape was cut through winter, then found a floor

The revision that matters happened between six and three months ago, when the FY2027 consensus stepped down sharply — revenue by about 4.9% and normalized EPS by about 6.6%. Since then both lines have barely moved, which reads less like a deteriorating story and more like estimates resetting to a level the street is now willing to hold.

Source: derived from vendor data.

EPS keeps beating while revenue runs light

Copart has beaten normalized EPS consensus in six of the past eight quarters, missing only twice — a big shortfall in 4Q FY2024 and again in 2Q FY2026. The biggest beat was 13.3% in 4Q FY2025. Revenue tells a softer story: surprises of -1.8% and -2.4% in the two prints before a +3.5% beat in 3Q FY2026. EPS clearing the bar while revenue lags points to cost and margin discipline carrying the surprises.

Source: derived from vendor data.

A flat FY2026, then growth resumes

The shape of the forward curve is a pause and a restart. Revenue and EPS are both modelled essentially flat in FY2026 against FY2025, before revenue grows 3.9%, 8.4% and 7.2% through FY2029 and normalized EPS rises 6.2% then 10% in FY2027 and FY2028. EBITDA tracks revenue upward, with the implied margin holding in the low-to-mid 40s across the visible years.

Source: derived from vendor data.

Source: derived from vendor data.

Coverage thins fast past FY2027

Read the outer years as a thin base, not a settled consensus. FY2027 draws 13 EPS estimates and 11 for revenue; by FY2029 both fall to 2, and the FY2029 EBITDA line rests on a single analyst. The ranges widen accordingly — FY2027 normalized EPS already spans $1.55 to $1.78.

Source: derived from vendor data.

The street is split five-five

Positioning is balanced rather than directional: five buys and two outperforms against five holds and one underperform, no sells, for a consensus recommendation score of 2.15. The ten price targets carry a mean of $40.30 and a median of $41, but a wide $26-to-$55 range — the high target is more than double the low, so the disagreement is about magnitude, not direction.

Source: derived from vendor data.